孟德尔随机化法分析循环氨基酸与孤独症谱系障碍的因果关系研究

朱冰泉, 吕丽娜, 齐晔, 陈赛景, 刘丹

中国儿童保健杂志 ›› 2025, Vol. 33 ›› Issue (9) : 954-958.

PDF(1032 KB)
PDF(1032 KB)
中国儿童保健杂志 ›› 2025, Vol. 33 ›› Issue (9) : 954-958. DOI: 10.11852/zgetbjzz2025-0503
科研论著

孟德尔随机化法分析循环氨基酸与孤独症谱系障碍的因果关系研究

  • 朱冰泉1, 吕丽娜1, 齐晔1, 陈赛景1, 刘丹2
作者信息 +

Causal relationship between circulating amino acids and autism spectrum disorder based on Mendelian randomization

  • ZHU Bingquan1, LYU Lina1, QI Ye1, CHEN Saijing1, LIU Dan2
Author information +
文章历史 +

摘要

目的 分析循环氨基酸水平与孤独症谱系障碍(ASD)的因果关系,为ASD的精准干预策略提供遗传学证据。 方法 基于欧洲人群全基因组关联研究(GWAS)汇总数据,采用两样本孟德尔随机化(MR)框架,纳入18 381例ASD患者和27 969例对照。筛选441个遗传工具变量(SNP),涵盖20种循环氨基酸。采用逆方差加权法(IVW),辅以加权中位数(WME)、MR-Egger回归及加权众数法(WM)评估因果效应,通过Cochran′s Q检验及MR-PRESSO方法验证结果的敏感性和多效性。 结果 因果分析结果显示,遗传预测的循环氨基酸水平与ASD风险无显著因果关联(IVW P>0.05),这一发现在MR-Egger回归、WME、WM分析中得到验证,经过MR-PRESSO异常值校正同样支持这一结论。但Cochran′s Q检验结果表明赖氨酸(Q=24.037, P=0.045)与亮氨酸(Q=23.713,P=0.049)存在显著异质性。MR-PRESSO检出色氨酸(全局P=0.001)与赖氨酸(全局P=0.046)存在水平多效性,但校正异常值后无显著的因果关联(校正后色氨酸β=-0.07,P=0.21,赖氨酸 β=0.12,P=0.09)。色氨酸、赖氨酸、蛋氨酸、精氨酸、苏氨酸的MR Egger回归或WM 95%CI异常宽泛。 结论 遗传预测的循环氨基酸水平与ASD无直接因果关系,但色氨酸、赖氨酸、蛋氨酸、精氨酸、苏氨酸、亮氨酸的结果稳健性不足,结果需谨慎解释。

Abstract

Objective To analyze the causal relationship between circulating amino acid levels and autism spectrum disorder (ASD), in order to provide genetic evidence for precision intervention strategies in ASD. Methods Based on summary data from genome-wide association studies (GWAS) in European populations, a two-sample Mendelian randomization (MR) framework was employed, incorporating 18 381 ASD cases and 27 969 controls.A total of 441 genetic instrumental variables (SNPs) were selected, covering 20 circulating amino acids.The inverse-variance weighted (IVW) method was used as the primary analysis, supplemented by weighted median (WME), MR-Egger regression, and weighted mode (WM) methods to assess causal effects.Sensitivity and pleiotropy were evaluated using Cochran′s Q test and MR-PRESSO. Results The causal analysis revealed no significant association between genetically predicted circulating amino acid levels and ASD risk (IVW P>0.05), this finding was consistent across MR-Egger regression, WME, and WM analysis.This conclusion remained robust after outlier correction via MR-PRESSO.However, Cochran′s Q test indicated significant heterogeneity for lysine (Q=24.037, P=0.045) and leucine (Q=23.713, P=0.049).MR-PRESSO detected horizontal pleiotropy for tryptophan (global P =0.001) and lysine (global P =0.046), but no significant causal associations persisted after outlier correction (corrected tryptophan β=-0.07, P=0.21, lysine β=0.12,P=0.09).The 95% confidence intervals for tryptophan, lysine, methionine, arginine, and threonine were exceptionally wide in MR-Egger regression or WM analysis. Conclusions Genetically predicted circulating amino acid levels show no direct causal relationship with ASD.However, the robustness of results for tryptophan, lysine, methionine, arginine, threonine, and leucine was limited, warranting cautious interpretation.

关键词

孤独症谱系障碍 / 孟德尔随机化 / 循环氨基酸 / 因果关系 / 遗传工具变量

Key words

autism spectrum disorder / Mendelian randomization / circulating amino acids / causal relationship / genetic instrumental variables

引用本文

导出引用
朱冰泉, 吕丽娜, 齐晔, 陈赛景, 刘丹. 孟德尔随机化法分析循环氨基酸与孤独症谱系障碍的因果关系研究[J]. 中国儿童保健杂志. 2025, 33(9): 954-958 https://doi.org/10.11852/zgetbjzz2025-0503
ZHU Bingquan, LYU Lina, QI Ye, CHEN Saijing, LIU Dan. Causal relationship between circulating amino acids and autism spectrum disorder based on Mendelian randomization[J]. Chinese Journal of Child Health Care. 2025, 33(9): 954-958 https://doi.org/10.11852/zgetbjzz2025-0503
中图分类号: R179   

参考文献

[1] Zeidan J, Fombonne E, Scorah J,et al.Global prevalence of autism: A systematic review update[J].Autism Rese, 2022, 15: 778-790.
[2] Chen M, Wei H, Chen L,et al.Autistic spectrum disorder, attention deficit hyperactivity disorder, and psychiatric comorbidities:A nationwide study[J].Research in Autism Spectrum Disorderse, 2015, 10: 1-6.
[3] Picardi A, Gigantesco A, Tarolla E,et al.Parental burden and its correlates in families of children with autism spectrum disorder: A multicentre study with two comparison groups[J].Clin Pract Epidemiol Ment Health, 2018, 14: 143.
[4] Nogueira-de-Almeida C, Zotarelli-Filho I, Nogueirade-Almeida M et al.Neuronutrients and central nervous system: A systematic review[J].Cent Nerv Syst Agents Med Chem, 2023, 23: 1-12.
[5] Li J, Zhai P, Bi L,et al.Associations between amino acid levels and autism spectrum disorder severity[J].BMC Psychiatry, 2025, 25(1):332.
[6] He W, Wu G.Metabolism of amino acids in the brain and their roles in regulating food intake[J].Adv Exp Med Biol, 2020, 1265:167-185.
[7] Hosseini S, Panahi-Azar A, Sheybani-Arani M,et al.Vitamins, minerals and their maternal levels′ role in brain development: An updated literature-review[J].Clin Nutr ESPEN, 2024, 63:31-45.
[8] Chen W, Chen Y, Peng M,et al.Plasma amino acid profile in children with autism spectrum disorder in Southern China: Analysis of 110 cases[J].J Autism Dev Disord, 2024, 54(4):1567-1581.
[9] Hou Y, Wu G.Nutritionally essential amino acids[J].Adv Nutr, 2018, 9: 849-851.
[10] Ng E, Lind P, Lindgren C,et al.Genome-wide association study of toxic metals and trace elements reveals novel associations[J].Hum Mol Genet, 2015, 24: 4739-4745.
[11] Rodríguez-Pérez C, Vrhovnik P, González-Alzaga B,et al.Socio-demographic, lifestyle, and dietary determinants of essential and possibly-essential trace element levels in adipose tissue from an adult cohort[J].Environ Pollut, 2018, 236: 878-888.
[12] Emdin C, Khera A, Kathiresan S.Mendelian randomization[J].JAMA, 2017, 318: 1925-1926.
[13] Skrivankova V, Richmond R, Woolf B,et al.Strengthening the reporting of observational studies in epidemiology using mendelian randomisation (STROBE-MR): Explanation and elaboration[J].BMJ, 2021, 375: n2233.
[14] skrivankova V, richmond R, woolf B,et al.strengthening the reporting of observational studies in epidemiology using mendelian randomization: The STROBE-MR statement[J].JAMA, 2021, 326: 1614-1621.
[15] Grove J, Ripke S, Als T,et al.Identification of common genetic risk variants for autism spectrum disorder[J].Nat Genet, 2019, 51: 431-444.
[16] Shin S, Fauman E, Petersen A,et al.An atlas of genetic influences on human blood metabolites[J].Nat Genet, 2014, 46: 543-550.
[17] Kettunen J, Demirkan A, Würtz P,et al.Genome-wide study for circulating metabolites identifies 62 loci and reveals novel systemic effects of LPA[J].Nat Commun, 2016, 7: 11122.
[18] Burgess S, Small DS, Thompson SG.A review of instrumental variable estimators for Mendelian randomization[J].Stat Methods Med Res, 2017, 26: 2333-2355.
[19] Burgess S, Thompson SG.Interpreting findings from Mendelian randomization using the MR-Egger method[J].Eur J Epidemiol, 2017, 32: 377-389.
[20] Olson A, Krall JR, Baranova A, et al.Nutritional intake and sensory processing in school-aged children with autism spectrum disorder[J].Nutrients, 2025, 17(4):604.
[21] Hendaus MA, Jomha FA, Alhammadi AH.Vasopressin in the amelioration of social functioning in autism spectrum disorder[J].J Clin Med, 2019, 8(7):1061.
[22] Khemir S, Halayem S, Azzouz H, et al.Autism in Phenylketonuria patients: From clinical presentation to molecular defects[J].J Child Neurol, 2016,31(7):843-849.
[23] Boccuto L, Chen CF, Pittman AR, et al.Decreased tryptophan metabolism in patients with autism spectrum disorders[J].Mol Autism,2013, 4(1):16.
[24] Ramaekers VT, Sequeira JM, Thöny B, et al.Oxidative stress, folate receptor autoimmunity, and csf findings in severe infantile autism[J].Autism Res Treat,2020, 2020:9095284.
[25] Tărlungeanu DC, Deliu E, Dotter CP, et al.Impaired amino acid transport at the blood brain barrier is a cause of autism spectrum disorder[J].Cell,2016,167(6):1481-1494.
[26] Ferguson BJ, Marler S, Altstein LL, et al.Psychophysiological associations with gastrointestinal symptomatology in autism spectrum disorder[J].Autism Res,2017,10(2):276-288.

基金

国家卫生健康委妇幼健康中心母婴营养与健康研究项目(2024FYH02);绍兴市卫生健康科技计划(2024SKY053)

PDF(1032 KB)

Accesses

Citation

Detail

段落导航
相关文章

/